摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,12-dimethyl-5,10-imino-10,11-dihydro-5H-dibenzocycloheptene | 70450-20-3

中文名称
——
中文别名
——
英文名称
5,12-dimethyl-5,10-imino-10,11-dihydro-5H-dibenzocycloheptene
英文别名
5,N-dimethyl-10,11-dihydro-5H-dibenzocyclohepten-5,10-imine;N,10-dimethyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine;5,12-dimethyl-5,10-imino-10,11-dihydro-5H-dibenzo[a,d]cycloheptene;1,16-Dimethyl-16-azatetracyclo[7.6.1.02,7.010,15]hexadeca-2,4,6,10,12,14-hexaene
5,12-dimethyl-5,10-imino-10,11-dihydro-5H-dibenzo<a,d>cycloheptene化学式
CAS
70450-20-3
化学式
C17H17N
mdl
——
分子量
235.329
InChiKey
VRDVKRKIXRRDOQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    18
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    3.2
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5,12-dimethyl-5,10-imino-10,11-dihydro-5H-dibenzocycloheptene 在 sodium tetrahydroborate 、 rhodium(III) chloride 作用下, 以 乙醇 为溶剂, 以49%的产率得到(+)-(5R,5aS,9aR,10R)-5a,6,7,8,9,9a,10,11-octahydro-N,5-dimethyl-5H-dibenzocyclohepten-5,10-imine
    参考文献:
    名称:
    Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801)
    摘要:
    Several hydrogenated derivatives of the potent NMDA antagonist 1 have been prepared and evaluated as competitive inhibitors of [3H]-1 binding. These compounds were also tested for their ability to act as noncompetitive antagonists of NMDA in vitro. These studies indicate that two aromatic rings are not strictly required for high-affinity binding or NMDA antagonism.
    DOI:
    10.1021/jm00165a026
  • 作为产物:
    参考文献:
    名称:
    Lanthanide-Catalyzed Hydroamination of Hindered Alkenes in Synthesis:  Rapid Access to 10,11-Dihydro-5H-dibenzo- [a,d]cyclohepten-5,10-imines
    摘要:
    DOI:
    10.1021/jo990626b
点击查看最新优质反应信息

文献信息

  • New Synthetic Route to 10,11-Dihydro-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>]cyclohepten-5,10-imines through Photoamination of 5-Alkoxy- and 5-Hydroxy-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>]cycloheptenes Followed by a Transannular Reaction with Acetic Acid
    作者:Masahide Yasuda、Tomoko Wakisaka、Ryuji Kojima、Kimiko Tanabe、Kensuke Shima
    DOI:10.1246/bcsj.68.3169
    日期:1995.11
    The photoadditions of ammonia and alkylamines (RNH2) to 5-hydroxy- and 5-alkoxy-5H-dibenzo[a,d]cycloheptene derivatives (2) occurred at the C10–C11 double bond upon the irradiation of 2 with RNH2 in the presence of p-dicyanobenzene. The resulting 5-substituted 10-alkylamino-10,11-dihydro-5H-dibenzo[a,d]cycloheptenes were converted to 5-substituted N-alkyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imines by a treatment with AcOH.
    氨和烷基胺(RNH2)对5-羟基和5-烷氧基-5H-二苯并[a,d]环庚烯衍生物(2)的加成发生在C10-C11双键处,这是在存在对二氰基苯的情况下,通过RNH2对2进行辐照实现的。所得到的5-取代的10-烷基氨基-10,11-二氢-5H-二苯并[a,d]环庚烯通过与AcOH处理,转化为5-取代的N-烷基-10,11-二氢-5H-二苯并[a,d]环庚烯-5,10-亚胺。
  • Nomoto, Takashi; Takayama, Hiroaki, Heterocycles, 1984, vol. 22, # 9, p. 1969 - 1972
    作者:Nomoto, Takashi、Takayama, Hiroaki
    DOI:——
    日期:——
  • NOMOTO, TAKASHI;TAKAYAMA, HIROAKI, HETEROCYCLES, 1984, 22, N 9, 1969-1972
    作者:NOMOTO, TAKASHI、TAKAYAMA, HIROAKI
    DOI:——
    日期:——
  • TAKAYAMA H.; NOMOTO T.; SUZUKI T.; TAKAMOTO M.; OKAMOTO T., HETEROCYCLES, 1979, 12, NO 1, 179
    作者:TAKAYAMA H.、 NOMOTO T.、 SUZUKI T.、 TAKAMOTO M.、 OKAMOTO T.
    DOI:——
    日期:——
  • CONJUGATES OF HUPERZINE AND ANALOGS THEREOF
    申请人:INSERO HEALTH INC.
    公开号:US20150191430A1
    公开(公告)日:2015-07-09
    Compounds and compositions for treating neurodegenerative diseases are described. The compounds include a therapeutic agent covalently linked with huperzine or an analog thereof through a linker. Methods of preparing the compounds are described. Methods of treating a neurodegenerative disease by administering compounds and compositions including a therapeutic agent covalently linked with huperzine or an analog thereof are described. Methods for delivering a therapeutic agent by administering the therapeutic agent covalently linked to huperzine or an analog thereof are described.
查看更多